Search research articles
Contact Us
Filters
Showing results (31-40 of 400) with videos related to
Page
of 40
Sort By:
Current Opinion in Gastroenterology
|
April 30, 2025
Gut-directed therapeutics in inflammatory bowel disease
Christina Kratschmer, David T Curiel, Matthew A Ciorba
Nature Reviews. Genetics
|
July 4, 2007
Engineering targeted viral vectors for gene therapy
Reinhard Waehler, Stephen J Russell, David T Curiel
Molecular Biotechnology
|
October 31, 2002
Genetically engineered intracellular single-chain antibodies in gene therapy
Guadalupe Bilbao, Juan Luis Contreras, David T Curiel
Journal of Virology
|
June 20, 2002
Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX
Igor P Dmitriev, Elena A Kashentseva, David T Curiel
Journal of Inherited Metabolic Disease
|
June 30, 2021
Mucopolysaccharidoses type I gene therapy
Sarah C Hurt, Patricia I Dickson, David T Curiel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2002
The presence of the adenovirus E3 region improves the oncolytic potency of conditionally replicative adenoviruses
Kaori Suzuki, Ramón Alemany, Masato Yamamoto, et al.
Hematology/Oncology Clinics of North America
|
September 10, 2003
Gene therapy for ovarian cancer: progress and potential
Tyler O Kirby, David T Curiel, Ronald D Alvarez
International Journal of Molecular Medicine
|
September 12, 2006
A conditionally replicative adenovirus that codes for a TK-GFP fusion protein (Ad5Delta24TK-GFP) for evaluation of the potency of oncolytic virotherapy combined with molecular chemotherapy
Tanja Hakkarainen, Akseli Hemminki, David T Curiel, et al.
Journal of Virology
|
August 7, 2002
Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein
Natalya Belousova, Valentina Krendelchtchikova, David T Curiel, et al.
Cancer Gene Therapy
|
September 20, 2020
Understanding and addressing barriers to successful adenovirus-based virotherapy for ovarian cancer
Rebeca Gonzalez-Pastor, Peter S Goedegebuure, David T Curiel
Page
of 40
Search research articles
Search
Showing results (31-40 of 400) with videos related to
Sort By:
Page
of 40
Current Opinion in Gastroenterology
|
April 30, 2025
Gut-directed therapeutics in inflammatory bowel disease
Christina Kratschmer, David T Curiel, Matthew A Ciorba
Nature Reviews. Genetics
|
July 4, 2007
Engineering targeted viral vectors for gene therapy
Reinhard Waehler, Stephen J Russell, David T Curiel
Molecular Biotechnology
|
October 31, 2002
Genetically engineered intracellular single-chain antibodies in gene therapy
Guadalupe Bilbao, Juan Luis Contreras, David T Curiel
Journal of Virology
|
June 20, 2002
Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX
Igor P Dmitriev, Elena A Kashentseva, David T Curiel
Journal of Inherited Metabolic Disease
|
June 30, 2021
Mucopolysaccharidoses type I gene therapy
Sarah C Hurt, Patricia I Dickson, David T Curiel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2002
The presence of the adenovirus E3 region improves the oncolytic potency of conditionally replicative adenoviruses
Kaori Suzuki, Ramón Alemany, Masato Yamamoto, et al.
Hematology/Oncology Clinics of North America
|
September 10, 2003
Gene therapy for ovarian cancer: progress and potential
Tyler O Kirby, David T Curiel, Ronald D Alvarez
International Journal of Molecular Medicine
|
September 12, 2006
A conditionally replicative adenovirus that codes for a TK-GFP fusion protein (Ad5Delta24TK-GFP) for evaluation of the potency of oncolytic virotherapy combined with molecular chemotherapy
Tanja Hakkarainen, Akseli Hemminki, David T Curiel, et al.
Journal of Virology
|
August 7, 2002
Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein
Natalya Belousova, Valentina Krendelchtchikova, David T Curiel, et al.
Cancer Gene Therapy
|
September 20, 2020
Understanding and addressing barriers to successful adenovirus-based virotherapy for ovarian cancer
Rebeca Gonzalez-Pastor, Peter S Goedegebuure, David T Curiel
Page
of 40